Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1975 Aug;38(8):794–798. doi: 10.1136/jnnp.38.8.794

Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa.

A Elithorn, M Lunzer, J Weinman
PMCID: PMC492074  PMID: 1185200

Abstract

A battery of computer-based psychological tests given to seven patients with chronic hepatic encephalopathy showed them to be intellectually impaired, particularly on speed-based measures, as compared with general hospital patients and with patients with cirrhosis but without clinical or electroencephalographic evidence of encephalopathy. Two of the seven patients in the latter group also showed evidence of cognitive impairment on some tests. The effects of levodopa were also evaluated by sequential assessment with these tests. Although there was some improvement in speed of performance on certain tasks and a suggestion of deterioration on other measures, there was little overall change. It is concluded that levodopa has an 'arousing' or antidepressant action and that its effect on intellectual functions is secondary to this alerting effect and is consequently dependent on the emotional and attentional status of the patient.

Full text

PDF
798

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birdsong J. H., McKinney A. S. Long-range motor performance changes in levodopa-treated patients with Parkinson's disease. Neurology. 1974 Feb;24(2):107–115. doi: 10.1212/wnl.24.2.107. [DOI] [PubMed] [Google Scholar]
  2. Botez M. I., Barbeau A. Letter: Long term mental changes in levodopa-treated patients. Lancet. 1973 Nov 3;302(7836):1028–1029. doi: 10.1016/s0140-6736(73)91121-5. [DOI] [PubMed] [Google Scholar]
  3. Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
  4. Godwin-Austen R. B., Tomlinson E. B., Frears C. C., Kok H. W. Effects of L-dopa in Parkinson's disease. Lancet. 1969 Jul 26;2(7613):165–168. doi: 10.1016/s0140-6736(69)91417-2. [DOI] [PubMed] [Google Scholar]
  5. Horvath T. B., Meares R. A. L-dopa and arousal. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):416–420. doi: 10.1136/jnnp.37.4.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kojima H., Yasukochi G. Treatment with L-DOPA in two cases of organic brain syndrome. Folia Psychiatr Neurol Jpn. 1973;27(2):155–166. doi: 10.1111/j.1440-1819.1973.tb00090.x. [DOI] [PubMed] [Google Scholar]
  7. Loranger A. W., Goodell H., Lee J. E., McDowell F. Levodopa treatment of Parkinson's syndrome. Improved intellectual functioning. Arch Gen Psychiatry. 1972 Feb;26(2):163–168. doi: 10.1001/archpsyc.1972.01750200067014. [DOI] [PubMed] [Google Scholar]
  8. Lunzer M., James I. M., Weinman J., Sherlock S. Treatment of chronic hepatic encephalopathy with levodopa. Gut. 1974 Jul;15(7):555–561. doi: 10.1136/gut.15.7.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Marsh G. G., Markham C. M., Ansel R. Levodopa's awakening effect on patients with Parkinsonism. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):209–218. doi: 10.1136/jnnp.34.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Meier M. J., Martin W. E. Intellectual changes associated with levodopa therapy. JAMA. 1970 Jul 20;213(3):465–466. [PubMed] [Google Scholar]
  11. O'Brien C. P., DiGiacomo J. N., Fahn S., Schwarz G. A. Mental effects of high-dosage levodopa. Arch Gen Psychiatry. 1971 Jan;24(1):61–64. doi: 10.1001/archpsyc.1971.01750070063008. [DOI] [PubMed] [Google Scholar]
  12. Read A. E., McCarthy C. F., Ajdukiewicz A. B., Brown G. J. Encephalopathy after portacaval anastomosis. Lancet. 1968 Nov 9;2(7576):999–1001. doi: 10.1016/s0140-6736(68)91295-6. [DOI] [PubMed] [Google Scholar]
  13. SUMMERSKILL W. H., DAVIDSON E. A., SHERLOCK S., STEINER R. E. The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Q J Med. 1956 Apr;25(98):245–266. [PubMed] [Google Scholar]
  14. Van Woert M. H., Heninger G., Rathey U., Bowers M. B., Jr L-dopa in senile dementia. Lancet. 1970 Mar 14;1(7646):573–574. doi: 10.1016/s0140-6736(70)90819-6. [DOI] [PubMed] [Google Scholar]
  15. Yahr M. D., Duvoisin R. C., Schear M. J., Barrett R. E., Hoehn M. M. Treatment of parkinsonism with levodopa. Arch Neurol. 1969 Oct;21(4):343–354. doi: 10.1001/archneur.1969.00480160015001. [DOI] [PubMed] [Google Scholar]
  16. Zeegen R., Drinkwater J. E., Dawson A. M. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J. 1970 Jun 13;2(5710):633–636. doi: 10.1136/bmj.2.5710.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zeegen R., Drinkwater J. E., Fenton J. C., Vince A., Dawson A. M. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Q J Med. 1970 Apr;39(154):245–263. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES